John Buatti, MD, FASTRO

Science Council Chair

University of Iowa, Iowa City, Iowa

EDUCATION

• MD, Georgetown University, Washington, D.C., 1986
• BS, (Biology and Theology majors) Georgetown University, Washington, D.C., 1982

POSTGRADUATE EDUCATION

• Residency, Radiation Oncology, Arizona University, 1989 - 1993
• Internship and Residency, Internal Medicine, Georgetown University, 1986 - 1989

ACADEMIC APPOINTMENTS

• Secondary Appointment, Department of Neurosurgery, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, 2009 - present
• Secondary Appointment, Department of Otolaryngology, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, 2004 - present
• Professor, Department of Radiation Oncology, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, 2001 - present
• Professor, Department of Radiology Carver College of Medicine, The University of Iowa, Iowa City, Iowa, 1999 - 2001
• Clinical Associate Professor, Department of Neurosurgery, Shands Cancer Center, University of Florida, Gainesville, Florida, 1999 - 2001
• Associate Professor, Department of Radiation Oncology, Shands Cancer Center, University of Florida, Gainesville, Florida, 1998 - 1999
• Joint Appointment, Department of Neurosurgery, Shands Cancer Center, University of Florida, Gainesville, Florida, 1997 - 1999
• Assistant Professor, Department of Radiation Oncology, Shands Cancer Center, University of Florida, Gainesville, Florida, 1993 - 1998

HOSPITAL APPOINTMENTS

• Co-Chair Clinical Operations Committee, Clinical Systems Committee University of Iowa Hospitals and Clinics, 2019 - 2021
• Co-Chair Clinical Enterprise Clinical Practice Strategy Subcommittee, 2021
• Deputy Director of Clinical Cancer Care, Holden Comprehensive Cancer Center, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, 2008 - 2012
• Chair, Department of Radiation Oncology, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, 2001 - present
• Director, Division of Radiation Oncology, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, 1999 - 2001
• Vice-Chair, Department of Radiology, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, 1999 - 2001

SERVICE TO ASTRO

• Master Class Theranostics – ASTRO Annual Meeting, 2019 - 2021
• Member - SNMMI/ASTRO Education & Training Working Group, 2019 - 2020
• Member - ASTRO Nominating Committee, 2018 - 2021
• Chair - ASTRO Theranostics Work Group, 2018 - 2021
• Moderator: ASTRO Panel, Advanced Quantitative Imaging for the Radiation Oncologist: Response Assessment and Targeting for Clinical Trials and Practice, A View from NCI’s Quantitative Imaging Network, Boston, 2016
• ASTRO Fellow (FASTRO), 2014
• ASTRO – Science Council Steering Committee, 2013 - 2017
• Speaker: AANS/ASTRO Stereotactic Radiosurgery Course for Neurosurgery & Radiation Oncology Residents, “Radiosurgery for Acoustic Neuromas” and “Evidence Based Radiosurgery,” Evanston, Illinois, 2012
• Co-Chair: ASTRO – IHERO Leadership Committee, 2012 - 2017
• Co-moderator in an oral scientific session at ASTRO’s 53rd Annual Meeting. Session Name: Head and Neck II: Targeted Biologics, Particle Therapies and Approaches to Reduce Toxicities of Radiotherapy. Miami, 2011
• Moderator: Scientific Session at ASTRO’s 52nd Annual Meeting in San Diego, November 2010
• Speaker: ASTRO IGRT IMRT SBRT Symposium, Dallas, 2010
• Abstract reviewer: ASTRO Annual Meeting, 2009 - 2011
• ASTRO 51st Annual Meeting. Scientific Panel (speaker) “Utilization of Quantitative Imaging (QI) for Tumor Response Assessment.” Chicago, 2009
• Speaker: ASTRO IGRT and SBRT Conference. “IGRT for Head and Neck Cancer.” Miami, 2009
• Speaker: ASTRO IGRT & SBRT Symposium, H&N Cancer, Miami, 2009
• Speaker: 2008 ASTRO IGRT Image Guided Radiotherapy Symposium. Workshop “IGRT How to: CNS and Head & Neck” Eyes on Screen Practicum. Newport Beach, California, 2008
• Member, ASTRO Research Evaluation Committee, 2004 - 2009
• Member: ASTRO Education Committee, 2004 - 2010
• Member: ASTRO Education Committee, 1998 - 2000
• Member: American Society for Radiation Oncology (ASTRO), 1989 - present

SERVICE TO OTHER ONCOLOGY OR RADIOLOGY ORGANIZATIONS

• Member – External Advisory Committee – Moffitt Cancer Center, 2017 - 2021
• SCAROP Executive Committee Member, 2017 - 2019
• National Cancer Institute (NCI)
  • Site Visit/Review Committee, University of Colorado Comprehensive Cancer Center, Cancer Center Support Grant Application, P30 CA046934. Review Panel Member. 2021
  • NIH - Peer-Review WebEx Meeting: “The Information Technology in Cancer Research” March 30-31, 2021
  • NIH - Special Emphasis Panel - Metastasis Research Network (RFA-CA-20-029). Feb 25-26, 2021 Virtual Review
  • Review Committee, Karmanos Cancer Center, Detroit. Grant application 2 P30 CA022453-39 May 6 - 8, 2020, Virtual Site Visit
  • Site Visit/Review Committee, University of Texas MD Anderson Cancer Center, Cancer Center Support Grant Application, 2 P30 CA016672-43. Review Panel Member. 2019
  • Review Committee, Cancer Center Support Grant Application, 2 P30 CA015083-45, Mayo Clinic Comprehensive Cancer Center. Rochester, Minnesota. 2018
  • NCI Special Emphasis Panel U24/UG3-UH3 application – March 2020
  • NIH – Emerging Imaging Technologies and Applications (EITA) – February 2020
  • NCI Program Project Review Panel (P01), Gaithersburg, Maryland, 2019
  • Organizing Committee Member - NCI Workshop on Artificial Intelligence in Radiation Oncology. NCI Shady Grove Campus, Rockville, Maryland. April 4-5, 2019
  • NCI Special Emphasis Panel U24/UG3-UH3/U01 applications - PAR-16-385: Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24); PAR-17-128: Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3); PAR-17-129: Quantitative Imaging (QI) Tools and Methods for Cancer Response Assessment (U01), 2018
  • Reviewer: NIH/ NCI Development of Informatics Technologies for Cancer Research and Management applications (R21, U01, U24, UG3), 2018
  • Reviewer: NCI Program Project Review II (P01), Gaithersburg, Maryland, 2018
  • Co-Chair Special Emphasis Panel – NCI Program Project Review (P01), Gaithersburg, Maryland, 2018
  • Reviewer - NIH/ NCI Development of Informatics Technologies for Cancer Research and Management applications (R21, U01, U24, UG3), 2018
  • NCI Site Visit Reviewer - The Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, 2017
  • Reviewer – U01 Applications PAR-16-111 “Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy” 2017
  • Reviewer – U01 Applications PAR-14-116, “Quantitative Imaging for Evaluation of Response to Cancer Therapies,” 2017
  • Reviewer – Carver Collaborative Pilot Grant (CPG), 2017
  • Clinical and Experimental Therapeutics (CET-3) Review panel for FY17 Breast Cancer Research Program (BCRP) for the development of Defense Congressionally Directed Medical Research Programs (CDMRP). Review Panel Member. 2017
  • NCI Site Visit Reviewer - Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, 2016
  • Reviewer – Grant Applications PAR 14-116 “Quantitative Imaging for Evaluation of Response to Cancer Therapies,” 2016
  • NCI Lasker Clinical Research Scholars Program, 2015
  • Reviewer: (NCI Omnibus R21) and PAR-14-007 “NCI Small Grants Program for Cancer Research (NCI Omnibus R03) Grant Review Study Section, 2015
  • Reviewer - Alvin J. Siteman Cancer Center (Washington University) Site Visit Review. St Louis, (Cancer Center Support Grant, P30), 2015
  • R01 Reviewer-NIH - Health Services Organization and Delivery (HSOD) 2016/01
  • Chair: NCI Review Special Emphasis Panel “Development of Innovative Algorithms for Processing & Analysis of In Vivo Images, 2014
  • Reviewer – Grant Applications PAR 14-116 “Quantitative Imaging for Evaluation of Response to Cancer Therapies,” 2014
  • NCI - Site Visit Reviewer, St. Jude Children’s Comprehensive Cancer Center, Memphis, Tennessee, 2013
  • Reviewer: NCI R21/R03 Applications, Cancer Therapy (Omnibus) Special Emphasis Panel, 2013
  • NCI IRG Subcommittee A - Parent Committee Meeting (Reporting for the St Jude Children's Research Hospital) Participant, 2013
  • NCI Special Emphasis Panel-Informatics Technology for Cancer Research – PAR 12-286-289, 2013
  • NCI Special Emphasis Panel Member - PAR-11-150 “Quantitative Imaging for Evaluation of Responses to Cancer Therapies,” 2013
  • NCI IRG Subcommittee A - Parent Committee Meeting (Reporting for the St Jude Children's Research Hospital) Participant, 2013
  • Panel Review SBIR Contract Proposals for Topic 306 “Image Processing Algorithm and Software Development for Oncology,” 2013
  • Cancer Center Support Grant P30 Site Visit MD Anderson, Houston, 2013
  • PAR 11-150 QIN – Reviewer (2) Study Sections-Spring and Fall), 2013
  • NCI-Site Visit Reviewer (P30) – Kimmell Cancer Center at Thomas Jefferson University, Philadelphia, 2012
  • NIH Review Panel – CCOP and MBCCOP, 2012
  • NIH Meeting Panel - ZRG1 OTC-C (05) Radiation Therapeutic Member Conflict, SEP 2012
  • NIH / NCI - Ad Hoc Review ZRG1 OTC-C(02) Radiation Therapeutics Study Section, 2011
  • Panel Review SBIR Contract Proposals for “Algorithms for Automated Quantitative Imaging of Tumor Microenvironment” and “Development of Innovative Algorithms/software for Processing and Analysis of in Vivo Images in Oncology”. 2011
  • NCI Site Visit Reviewer-Abramson Comprehensive Cancer Center, University of Pennsylvania, Philadelphia, 2010
  • RC-4 ARRA Review, 2010
  • P30 CCSG Grant Ad Hoc Reviewer (3 institutions), 2009 - 2011
  • P30 CCSG Grant Ad Hoc Reviewer-Duke University, Raleigh-Durham, North Carolina, 2009
  • P30 ARRA Competitive Revision Supplement Applications Review Panel 2009
  • National Cancer Institute IRG Committee Ad Hoc Reviewer, 2009
  • National Cancer Institute Subcommittee G Education Meeting, 2009
  • National Institute of Health Loan Repayment Program Review Panel, 2004 - 2017
  • National Cancer Institute. Advanced Technology QA Center for Radiation Oncology Review Panel, 2003
  • National Institute of Health, NINDS, PO-1 Proposal Ad Hoc Review Panel, 1999
  • Pediatric Oncology Group of UOI Grant Proposal. Ad Hoc Review Panel, 1999
• Quantitative Imaging Network (QIN)
  • QIN Coordinating Committee T-Con, 2013 - 2015
  • Committee Chair, QIN Clinical Trials Design Development Working Group, 2014 - 2015
  • Chairman, QIN Steering Committee, 2010 - 2011
• Reviewer - P13-19 Technology Foundation STW Programme Proposal “Visual technology integrating quantitative patient outcomes to support multidisciplinary clinical decision making,” Netherlands, 2016
• Panel Reviewer – Italian Association for Cancer Research (AIRC), 2015 - 2017
• Reviewer – P13-19 Technology Foundation STW Programme Proposal “Radiomics – Non-invasive Stratification of Tissue Heterogeneity for Personalized Medicine – Radiomics STRaTeGy.” Netherlands, 2014
• Committee Co-Chair, Clinical Trials Working Group, NCI Quantitative Imaging Network, 2013 - 2014
• Panel Member – ACR Appropriate Criteria® Expert Panel on Radiation Oncology-Brain Metastases, American College of Radiology, 2012 - 2015
• Member, Board of Directors, Commission on Accreditation of Medical Physics Educational Programs (CAMPEP), 2012 - 2015
• Focused Ultrasound Foundation Research Award Program, 2012
• Examiner, Oral Boards Radiation Oncology, Central Nervous System and Pediatrics. 2010-2011
• 5 Year Review Committee of James Larner MD, Professor and Chair of Radiation Oncology, University of Virginia, 2010
• International RadioSurgery Association Guideline Initiative – Pituitary Adenomas, 2005
• Iowa Society of Therapeutic Radiation Oncology (ISTRO)
  • President, (ISTRO), 2005 - 2007
  • Vice-President, (ISTRO), 2003 - 2005
• ACR Guidelines for Performance of Stereotactic Radiosurgery, 2005
• International Stereotactic Radiosurgery Society
  • Education Committee, 2003 - 2005
  • Publications Committee, 2003 - 2005
  • Newsletter Committee, 2003 - 2005
• Selected to Board for International Society for Stereotactic Radiosurgery (2003-2005), Japan, 2003
• Department of Defense – Breast Cancer Concept Review Panel Member, 2005
• Department of Defense - Chairman, Prostate Cancer Research Program Review Panel – Radiation Oncology, 2004 - 2008
• Angoff Meeting for CNS Tumors for ABR, 2004 - 2008
• Item writer for ACR Certification Exam, American College of Radiology, 2003–2006, 2012
• Pediatric Oncology Group, Radiotherapy Section Review Panel, Jacksonville, Florida, 2002
• International Society of Stereotactic Radiosurgery-Scientific Program Committee, 2000
• Department of Defense – CDRMP Prostate Cancer Research Program. Panel Member on Therapeutic Intervention, 2001
• American Association of Neurosurgery Consensus Guidelines for Treatment of Malignant Gliomas, 2000 - 2006
• A Phase I Study of Stereotactic Radiosurgery for Recurrent Pediatric Brain Tumors. Pediatric Brain Tumor Consortium Trial, 2004
• Ependymoma Subcommittee, Children’s Oncology Group, 1999–2000
• American Board of Radiology-Recertification Board Examination Item Writer on Central Nervous System Tumors, 1998 - 2001
• Study Co-Chair, Eastern Cooperative Oncology Group Trial E6397: A Phase II Trial of Radiosurgery for 1 to 3 Newly Diagnosed Metastases from Renal Cell, Melanoma and Sarcoma, 1998
• A Randomized Trial of Best Supportive Care with or without Palliative Radiotherapy in Poor Prognosis High Grade Glioma (BR09). Medical Research Council. London, England. 1998
• Brain Tumor Core Committee, Pediatric Oncology Group, 1997 - 1999
• Co-Chair, Stereotactic Radiosurgery Subcommittee, Pediatric Oncology Group Brain Tumor Group, 1997 - 1999
• Ad Hoc Committee to Develop Criteria for Quality Assurance of 3D-Conformal Radiotherapy, Pediatric Oncology Group, 1997
• RT Study Coordinator, POG 9432: A Phase II Study of Pre-Irradiation Chemotherapy in Newly Diagnosed Children with Intracranial Ependymoma, 1996 - 1999

BIOGRAPHICAL SKETCH

Dr. Buatti is Professor and the Chair of the Department of Radiation Oncology, a position that he has held with distinction since 2001, when he established an independent department at the University of Iowa Hospitals and Clinics. In 2005, he opened Iowa’s first Center of Excellence in Image Guided Radiation Therapy, which was innovative for its use of advanced 3D imaging including a 3T MR scanner and 40 slice respiratory-gated PET/CT scanner to better locate and treat tumors. As a clinician, he is a leading authority on the treatment of cranial malignancies. He is a prolific scholar having authored or co-authored more than 250 peer-reviewed publications. He has published 22 book chapters.

With a lifelong commitment to improve the quality of cancer imaging in therapy he served as the first chair of the Steering Committee for the Quantitative Imaging Network (QIN) and Chair of the Clinical Trials Design and Development Working Group and was a member of the Coordinating Committee for QIN. He has served on the ASTRO Education Committee, as Co-Chair of the ASTRO IHE-RO (Integrating Health Enterprise-Radiation Oncology) and served on the ASTRO Science Council Steering Committee. He chairs the ASTRO task force on Theranostics.

He is an advocate for diversity in the workplace and encourages the development of scientist-investigators through summer internships and the active recruitment of minorities. He supports an active Holman Pathway program for residents as well as a graduate program in Free Radical and Radiation Biology within his department.